U.S. Supreme Court Upholds the ACA
The nation's highest court has upheld the ACA three times.
The U.S. Supreme Court issued a ruling this morning upholding the ACA.
The Associated Press reported that the justices, in a 7-2 vote, ruled that Texas, other Republican-led states and individuals didn’t have a right to bring their suit in federal court.
This is the third time that the Supreme Court has heard a legal challenge to the 2010 law and left the law intact
The court ruling did not take up the larger issues in the case, California v. Texas, and the question of whether one provision was legally "severable" from the rest of the sprawling healthcare legislation.
Instead, the justices decided that the plaintiffs lacked standing to bring a constitutional challenge.
Justice Stephen Breyer wrote the majority opinion, which was joined by two Trump-appointed justices, Brett Kavanaugh and Amy Coney Barrett. Justice Samuel Alito wrote a dissenting opinion, which was joined by Justice Neil Gorsuch.
"After numerous legal challenges and efforts to repeal it, the ACA stands and is as popular as it has ever been," tweeted Larry Levitt, executive vice president for health policy for the Kaiser Family Foundation.
Optimizing narcolepsy care: Diagnosis, treatment and patient access | Written recap
April 4th 2025In a recent Managed Healthcare Executive K-Cast video series, R. Robert Auger, M.D., a psychiatrist and sleep specialist at the Mayo Clinic in Rochester, Minnesota, spoke about the diagnosis and treatment of narcolepsy and idiopathic hypersomnia. This is a written recap of that series.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Exploring the Wide World of GLP-1s | AMCP Annual 2025
April 3rd 2025Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their effects on various other conditions, such as sleep apnea, substance use disorder and Alzheimer’s disease, according to panelists participating in a keynote session of the Academy of Managed Care Pharmacy annual meeting today in Houston.
Read More
